Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $55.43 million versus the consensus estimate of $48.08 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Bernstein SocGen on Cintas (CTAS): 'Setting up for a margin and EPS beat'
• DA Davidson Reiterates Buy Rating on EVI Industries Inc. (EVI) Following Q4 Results